An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.
In PLOS this week: ancient steppe bison mitochondrial genome, proteomic study of Sauvignon Blanc grapes, and more.
Researchers isolate DNA from a 170,000-year-old Neanderthal skeleton.
QDx will develop, market, and process the QPredict Prostate Mitomic Test, which will be based on Mitomics' flagship mitochondrial DNA-based prostate cancer diagnostic.
A new grant program aims to fund research that will study mitochondrial genomes for their potential uses in diagnosing, identifying, and monitoring cancer.
The institute seeks to fund researchers who will study biomarkers that could detect mitochondrial dysfunction and its links to environmental stressors and exposures.
Mitomics, formerly called Genesis Genomics, is set to launch its first mitochondrial genomics-based test, for prostate cancer as it moves from an R&D shop to a commercial entity.
In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.
British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.
An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.
The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.